CCA
MRK icon

Childress Capital Advisors’s Merck MRK Stock Holding History

Childress Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.7M Sell
21,037
-905
-4% -$106K 0.44% 44
2026
Q1 		$2.64M Sell
21,942
-877
-4% -$101K 0.48% 36
2025
Q4 		$2.4M Buy
22,819
+9,529
+72% +$894K 0.39% 46
2025
Q3 		$1.12M Buy
13,290
+1,062
+9% +$87.5K 0.2% 81
2025
Q2 		$968K Buy
12,228
+2,065
+20% +$164K 0.24% 67
2025
Q1 		$912K Sell
10,163
-675
-6% -$63K 0.26% 59
2024
Q4 		$1.08M Sell
10,838
-1,540
-12% -$159K 0.3% 56
2024
Q3 		$1.41M Buy
12,378
+62
+0.5% +$7.37K 0.38% 46
2024
Q2 		$1.52M Buy
12,316
+1,325
+12% +$171K 0.43% 40
2024
Q1 		$1.45M Sell
10,991
-407
-4% -$50.2K 0.42% 46
2023
Q4 		$1.24M Buy
11,398
+88
+0.8% +$9.13K 0.37% 47
2023
Q3 		$1.16M Buy
11,310
+9,374
+484% +$1.01M 0.38% 47
2023
Q2 		$223K Sell
1,936
-3,060
-61% -$347K 0.09% 67
2023
Q1 		$532K Sell
4,996
-5,440
-52% -$587K 0.23% 48
2022
Q4 		$1.16M Buy
10,436
+326
+3% +$33.3K 0.38% 47
2022
Q3 		$890K Sell
10,110
-318
-3% -$28.4K 0.35% 55
2022
Q2 		$951K Buy
10,428
+638
+7% +$56.6K 0.38% 52
2022
Q1 		$802K Buy
9,790
+779
+9% +$61.4K 0.28% 68
2021
Q4 		$691K Sell
9,011
-2,372
-21% -$189K 0.29% 68
2021
Q3 		$844K Buy
11,383
+4,309
+61% +$328K 0.34% 61
2021
Q2 		$550K Sell
7,074
-2,247
-24% -$167K 0.25% 66
2021
Q1 		$685K Buy
9,321
+2,351
+34% +$173K 0.31% 57
2020
Q4 		$544K Buy
+6,970
New +$533K 0.32% 38

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Childress Capital Advisors's MRK Position: Q2 2026 in Review

Childress Capital Advisors reduced its Merck (MRK) stake by 4.1% in Q2 2026, selling an estimated $106K and leaving 21,037 shares worth $2.7M. The position accounts for 0.44% of the portfolio, ranked #44.

Childress Capital Advisors first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. 3,839 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Childress Capital Advisors held 21,037 shares of Merck worth $2.7M as of Q2 2026.
  • Childress Capital Advisors sold 905 Merck shares in Q2 2026, an estimated $106K.
  • Merck made up 0.44% of Childress Capital Advisors's portfolio in Q2 2026, its #44 holding.
  • Childress Capital Advisors first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • 3,839 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Childress Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.